Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Implications for breast cancer treatment in those who are obese or diabetic.

Share :

EBCC 9

19 - 21 Mar 2014
Published: 3 Apr 2014
Views: 2737
Rating:
Save
Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany

At a press conference during the EBCC, Dr Fontanella discussed the implications of both obesity and type 2 diabetes for breast cancer treatment.

Read the article or watch the interview for a deeper look.

Related Videos

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos
The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )
1 Apr 2025

Insights into germline genetic screening of breast cancer patients

Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura
Insights into germline genetic screening of breast cancer patients ( Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura )
10 Jan 2025

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions

Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions ( Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia )
28 Nov 2024

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC

Prof Nicolas Girard - Institut Curie, Paris, France
Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )
14 Sep 2024

The Southeast Asian Breast Cancer Symposium; background, aims and successes

Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023

OncoAlert Round Up for August 25th - 31st, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 25th - 31st, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Sep 2023

Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis

Dr Chiara Molinelli - Università degli Studi di Genova, Genoa, Italy
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis ( Dr Chiara Molinelli - Università degli Studi di Genova, Genoa, Italy )
6 Jun 2023

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation